$9 Million is the total value of ALTEGRIS ADVISORS, L.L.C.'s 14 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 185.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | SPDR S&P 500 ETF TRput | $6,586,000 | – | 35,000 | +100.0% | 37.07% | – | |
New | POWERSHARES QQQ TRUSTput | $2,193,000 | – | 25,000 | +100.0% | 12.34% | – | |
New | GT ADVANCED TECHNOLOGIES INCnote 3.000%12/1 | $1,213,000 | – | 750,000 | +100.0% | 6.83% | – | |
New | WEB COM GROUP INCnote 1.000% 8/1 | $1,177,000 | – | 1,000,000 | +100.0% | 6.62% | – | |
New | ALERE INCnote 3.000% 5/1 | $1,099,000 | – | 1,000,000 | +100.0% | 6.18% | – | |
New | RAIT FINANCIAL TRUSTnote 4.000%10/0 | $975,000 | – | 1,000,000 | +100.0% | 5.49% | – | |
New | HOME INNS & HOTELS MGMT INCnote 2.000%12/1 | $967,000 | – | 1,000,000 | +100.0% | 5.44% | – | |
New | CIENA CORPnote 0.875% 6/1 | $890,000 | – | 875,000 | +100.0% | 5.01% | – | |
New | SALIX PHARMACEUTICALS INCnote 1.500% 3/1 | $845,000 | – | 500,000 | +100.0% | 4.76% | – | |
New | AMERICAN RLTY CAP PPTYS INCnote 3.750%12/1 | $816,000 | – | 750,000 | +100.0% | 4.59% | – | |
New | AMERICAN RLTY CAP PPTYS INCnote 3.000% 8/0 | $532,000 | – | 500,000 | +100.0% | 2.99% | – | |
New | ENDOLOGIX INCnote 2.250%12/1 | $475,000 | – | 500,000 | +100.0% | 2.67% | – | |
Exit | TIBCO SOFTWARE INCnote 2.250% 5/0 | $0 | – | -250,000 | -100.0% | -2.46% | – | |
Exit | CIENA CORPnote 0.875% 6/1 | $0 | – | -375,000 | -100.0% | -3.77% | – | |
Exit | ALBANY MOLECULAR RESH INCnote 2.250%11/1 | $0 | – | -500,000 | -100.0% | -4.56% | – | |
Exit | JEFFERIES GROUP INC NEWdbcv 3.875%11/0 | $0 | – | -500,000 | -100.0% | -5.21% | – | |
Exit | NUANCE COMMUNICATIONS INCnote 2.750%11/0 | $0 | – | -545,000 | -100.0% | -5.24% | – | |
Exit | OMNICARE INCdbcv 3.250%12/1 | $0 | – | -500,000 | -100.0% | -5.26% | – | |
Exit | WEB COM GROUP INCnote 1.000% 8/1 | $0 | – | -500,000 | -100.0% | -5.53% | – | |
Exit | ALERE INCnote 3.000% 5/1 | $0 | – | -500,000 | -100.0% | -5.54% | – | |
Exit | RADIAN GROUP INCnote 3.000%11/1 | $0 | – | -500,000 | -100.0% | -6.99% | – | |
MTCN | Exit | ARCELORMITTAL SA LUXEMBOURGmand cv nt 16 | $0 | – | -34,000 | -100.0% | -8.71% | – |
Exit | GT ADVANCED TECHNOLOGIES INCnote 3.000%10/0 | $0 | – | -750,000 | -100.0% | -10.13% | – | |
Exit | HOME INNS & HOTELS MGMT INCnote 2.000%12/1 | $0 | – | -1,000,000 | -100.0% | -10.29% | – | |
Exit | VECTOR GROUP LTDfrnt 1/1 | $0 | – | -1,000,000 | -100.0% | -11.61% | – | |
Exit | SALIX PHARMACEUTICALS INCnote 1.500% 3/1 | $0 | – | -1,000,000 | -100.0% | -14.69% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Altegris Holdings, Inc. #1
- Altegris Holdings II, Inc. #2
- AqGen Liberty Acquisition Inc. #3
- AqGen Liberty Management I, Inc. #4
- AqGen Liberty Holdings, LLC #5
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
QQQ US 11/18/16 P113 | 9 | Q3 2016 | 49.0% |
ALBANY MOLECULAR RESH INC | 7 | Q2 2016 | 9.4% |
INFINERA CORPORATION | 7 | Q2 2016 | 12.2% |
VEREIT Inc Convertible 3% Due 8/1/2018 FA1 | 7 | Q3 2015 | 8.8% |
Allergan Public Limited Company Preferred | 6 | Q3 2016 | 21.7% |
VEREIT Inc Convertible 3 3/4% Due 12/15/2020 JD15 | 6 | Q3 2015 | 4.6% |
Salesforce.com Inc Convertible 0 1/4% Due 4/1/2018 AO1 | 5 | Q3 2016 | 18.7% |
Palo Alto Networks, Inc 144A Due 7/1/2019 At Mat | 5 | Q3 2016 | 11.1% |
NXP SEMICONDUCTORS N V | 4 | Q3 2016 | 15.7% |
PRICELINE GRP INC | 4 | Q4 2015 | 9.6% |
View ALTEGRIS ADVISORS, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-NT | 2024-04-02 |
13F-NT | 2024-02-14 |
13F-NT | 2023-11-09 |
13F-NT | 2023-08-10 |
13F-NT | 2023-05-09 |
13F-NT | 2023-02-15 |
13F-NT | 2022-10-28 |
13F-NT | 2022-07-26 |
13F-NT | 2022-05-11 |
13F-NT | 2022-02-04 |
View ALTEGRIS ADVISORS, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.